Invivyd expects to advance VBY329 toward IND readiness in 2H 2026 for development in pediatric RSV prophylaxis, a blockbuster pharmaceutical market in 2024, expected to grow to $3-$4 billion in annual ...
Ensure that arrangements are in place with the AI technician and have enough help to ensure job goes smoothly.
A Public Health Alerts report today details successful administration of intramuscular immunoglobulin (IMIG) as post-exposure ...
Credit: Getty Images The GINA 2026 update addresses primary care management of asthma exacerbations, selecting biologics, identifying fatality risks, minimizing OCS use, and more. The Global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results